Recombinant Human Cadherin-6 (CDH6)

Molecular Structure and Characteristics

Cadherin-6 belongs to the class II cadherin family of calcium-dependent cell adhesion molecules. Its distinctive molecular structure includes five extracellular domains and a large cytoplasmic domain that facilitates interaction with catenin molecules . What distinguishes CDH6 from other cadherin family members such as CDH1, CDH2, or CDH3 is the presence of RGD motifs and the His-Ala-Val (HAV) motif in its extracellular domains, which are essential for the stabilization and clustering of adjacent monomers .

The complete human CDH6 gene encodes a typical cadherin molecule consisting of 790 amino acids . Sequence analysis has revealed that human CDH6 shows extremely high homology (97% for the putative mature protein) with rat K-cadherin, suggesting that CDH6 is the human counterpart of rat K-cadherin . This high degree of conservation across species underscores the fundamental importance of this protein in biological systems.

The recombinant form of human CDH6 typically includes specific regions of the native protein. Commercial preparations often feature the extracellular domain (Thr22-Ala615 & Ser54-Ala615) fused to a human IgG1 Fc region (Pro100-Lys330) and a 6-His tag for purification purposes .

Expression Pattern in Normal Tissues

CDH6 exhibits a tissue-specific expression pattern in normal human tissues. Northern blot analysis using specific probes corresponding to the signal and precursor sequence has revealed that brain, cerebellum, and kidney show strong expression of CDH6 . This expression pattern aligns with CDH6's known involvement in the morphogenesis of the central nervous system and kidney .

In contrast, tissues such as lung, pancreas, and gastric mucosa demonstrate only weak expression of CDH6 . Interestingly, normal liver tissue does not express detectable levels of CDH6, which becomes significant when considering the protein's abnormal expression in liver cancer .

In the reproductive system, CDH6 localizes to the endometrial luminal epithelial cell surface specifically during the mid-secretory/receptive phase of the menstrual cycle . This temporal regulation suggests a specialized function in reproductive processes, particularly in preparing the endometrium for embryo implantation.

Table 2: Expression Pattern of Cadherin-6 in Normal Human Tissues

Role in Cell Adhesion

As a member of the cadherin family, CDH6 primarily functions as a cell adhesion molecule. In vitro studies have demonstrated that recombinant human CDH6 can support cell adhesion, with more than 30% of cells adhering to CDH6-coated plates after 30 minutes at 37°C . This adhesive capacity is critical for maintaining tissue architecture and cellular organization.

On a molecular level, CDH6 mediates homophilic cell-cell adhesion through its extracellular domains while its cytoplasmic domain interacts with catenin molecules to establish connections with the cytoskeleton . This interaction forms part of the adhesion junction complex that provides mechanical strength to cellular attachments.

Gene Ontology (GO) analysis has confirmed that CDH6 is associated with multiple terms including "cell-cell adhesion via plasma membrane adhesion," "plasma membrane adhesion molecules," and "collagen-containing extracellular matrix" . These associations further validate the central role of CDH6 in cellular adhesion processes.

Table 3: Pathways Associated with Cadherin-6 Expression

Involvement in Tissue Morphogenesis

CDH6 plays a significant role in tissue morphogenesis, particularly in the development of the central nervous system and kidney . During embryonic development, the precise expression patterns of different cadherin subtypes guide cell sorting and tissue boundary formation.

In the central nervous system, CDH6 contributes to the correct positioning of neurons . Research has shown that other cadherins can compensate for the loss of CDH6 to maintain proper neuronal positioning in mouse models , highlighting the redundancy built into developmental systems.

Weighted gene co-expression network analysis (WGCNA) has revealed correlations between CDH6 and pathways involved in nuclear division, chromosome segregation, and mitotic nuclear division . These associations suggest broader roles for CDH6 in cell proliferation and tissue growth beyond simple adhesion functions.

Function in Embryo Implantation

One of the most clinically relevant functions of CDH6 is its role in embryo implantation. The endometrial luminal epithelium represents the first point of attachment for embryos during implantation, and failure of embryos to firmly adhere results in implantation failure and infertility .

Research has demonstrated that CDH6 localizes to the endometrial luminal epithelial cell surface specifically during the mid-secretory/receptive phase, when the endometrium is prepared for embryo attachment . This temporal regulation suggests that CDH6 is one of the adhesion molecules that contribute to establishing endometrial receptivity.

Functional studies using in vitro models have provided direct evidence for CDH6's role in implantation. When CDH6 is knocked down in Ishikawa cells (a receptive endometrial epithelial cell line), their adhesive capacity to HTR8/SVneo trophoblast spheroids (which model the implanting embryo) is significantly reduced . This experimental evidence strongly supports the hypothesis that CDH6 is essential for successful embryo implantation.

Applications in Research

Recombinant Human Cadherin-6 serves as a valuable tool in various research applications. One primary use is in cell adhesion assays, where it can be coated onto surfaces to study the adhesive properties of cells. When plates are coated with Recombinant Human Cadherin-6 Fc Chimera (5 μg/mL with 100 μL/well), more than 30% of appropriate cells will adhere after 30 minutes at 37°C .

Beyond adhesion assays, Recombinant Human Cadherin-6 is employed in investigating cell migration, tissue morphogenesis, and embryo implantation. It provides a controlled system for studying the specific contributions of CDH6 to these processes without the confounding variables present in complex in vivo models.

In cancer research, Recombinant Human Cadherin-6 offers opportunities to explore the role of this protein in tumor progression and metastasis, potentially leading to new therapeutic strategies targeting CDH6-mediated processes in cancer cells.

Infertility and Implantation Failure

Clinical studies have revealed a significant correlation between CDH6 expression levels and fertility status. Immunohistochemical analysis of endometrial tissues has shown that women with primary infertility exhibit reduced CDH6 immunolocalization in the luminal and glandular epithelium compared to women with normal fertility . This reduction is particularly evident during the mid-secretory phase of the menstrual cycle, which corresponds to the window of implantation.

Semi-quantification of CDH6 staining intensity has confirmed that this reduction is statistically significant . The decreased expression of CDH6 in the endometrium of women with infertility suggests that this adhesion molecule plays a critical role in establishing endometrial receptivity for embryo implantation.

Functional studies using cellular models have provided mechanistic insights into how CDH6 deficiency might contribute to implantation failure. When CDH6 is knocked down in Ishikawa cells (which model receptive endometrial epithelium), their ability to adhere to trophoblast spheroids (which model the implanting embryo) is significantly compromised . This experimental evidence directly links CDH6 deficiency to impaired embryo attachment, a key step in the implantation process.

Expression in Cancer

CDH6 exhibits altered expression patterns in various cancer types, suggesting its involvement in tumor biology. Interestingly, while normal liver tissue does not express detectable levels of CDH6, four out of six hepatocellular carcinoma cell lines examined showed abundant CDH6 expression . This cancer-specific upregulation points to a potential role for CDH6 in liver cancer development or progression.

Similarly, strong CDH6 expression has been observed in renal carcinoma cell lines, which aligns with the protein's normal expression in kidney tissue . This suggests that CDH6 might retain its expression pattern during the malignant transformation of kidney cells or potentially be further upregulated.

In small cell lung carcinoma (SCLC), an interesting pattern emerges: among 15 SCLC cell lines examined, all 11 CDH6-positive lines were classified as the "classic" type, whereas the CDH6-negative cell lines were all of the "variant" type . This correlation between CDH6 expression and SCLC subtype classification suggests that CDH6 might serve as a molecular marker for distinguishing SCLC subtypes.

In gastric cancer, high expression of CDH6 correlates with tumor progression and poor prognosis . Studies have found that CDH6 can promote epithelial-mesenchymal transition (EMT) and cancer metastasis by attenuating autophagy in certain cancer contexts . This suggests that CDH6 might actively contribute to the aggressive behavior of cancer cells rather than merely serving as a marker.